Rein Biotech: Shareholder Qin Benjun's pledge extension postponed to July 2026.

Rhein Biotech announced that its major shareholder Qin Benjun has extended the repurchase of 102 million shares pledged to Guohai Securities, accounting for 37.47% of his holding and 13.71% of the company's total share capital. The pledge started on July 28, 2022, was originally due on January 16, 2026, and has been extended to July 16, 2026. Qin Benjun holds 271 million shares, accounting for 36.59% of the total shares, and has pledged a total of 173 million shares, representing 63.64% of his holding and 23.29% of the company's total share capital.